|
Ispecimen Inc (NASDAQ: ISPC) |
|
Ispecimen Inc
ISPC's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Ispecimen Inc's sales fell
by -58.93 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 1998
Medical Laboratories industry recorded
growth of revenues by 2.95 %
Ispecimen Inc net loss decreased from $-3 millions, to $-2 millions in first quarter of 2025,
• More on ISPC's Growth
|
|
Ispecimen Inc realized a net loss in trailing twelve months.
Ispecimen Inc realized cash reduction of $ -0.73 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.25.
Medical Laboratories industry's Price to Sales ratio is at 2.26.
• More on ISPC's Valuation
|
|
|
|
|
Ispecimen Inc realized net loss in trailing twelve months.
Ispecimen Inc realized cash outflow of $ -0.73per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.25.
Medical Laboratories industry's Price to Sales ratio is at 2.26.
Ispecimen Inc Price to Book Ratio is at 1.34 lower than Industry Avg. of 329.69. and higher than S&P 500 Avg. of 0.01
• More on ISPC's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com